{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T14:21:21Z","timestamp":1792419681203,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.urolonc.2024.03.006","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T15:54:40Z","timestamp":1712591680000},"page":"179-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Urinary extracellular vesicles-encapsulated miRNA signatures: A new paradigm for urinary bladder cancer diagnosis and classification"],"prefix":"10.1016","volume":"42","author":[{"given":"Sukhad","family":"Kural","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakshi","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parimal","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5117-3522","authenticated-orcid":false,"given":"Lalit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2024.03.006_bib0001","doi-asserted-by":"crossref","first-page":"04109","DOI":"10.7189\/jogh.13.04109","article-title":"The global landscape of bladder cancer incidence and mortality in 2020 and projections to 2040","volume":"13","author":"Zhang","year":"2023","journal-title":"J Glob Health"},{"issue":"7","key":"10.1016\/j.urolonc.2024.03.006_bib0002","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00262-023-03376-9","article-title":"Tumor microenvironment as a predictive factor for immunotherapy in non-muscle-invasive bladder cancer","volume":"72","author":"Semeniuk-Wojta\u015b","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.urolonc.2024.03.006_bib0003","first-page":"17022","article-title":"Bladder cancer","volume":"3","author":"Sanli","year":"2017","journal-title":"Nat Rev"},{"issue":"6","key":"10.1016\/j.urolonc.2024.03.006_bib0004","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.urology.2005.07.062","article-title":"Bladder cancer: epidemiology, staging and grading, and diagnosis","volume":"66","author":"Kirkali","year":"2005","journal-title":"Urology"},{"issue":"10","key":"10.1016\/j.urolonc.2024.03.006_bib0005","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-231192","article-title":"Primary clear-cell urothelial carcinoma of urinary bladder: a not-so-clear entity with review of literature","volume":"12","author":"Kumar","year":"2019","journal-title":"BMJ Case Rep"},{"issue":"2","key":"10.1016\/j.urolonc.2024.03.006_bib0006","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.ju.0000076621.71247.6c","article-title":"Expectant management of small, recurrent, noninvasive papillary bladder tumors","volume":"170","author":"Soloway","year":"2003","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.03.006_bib0007","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/jcp.2007.049312","article-title":"Morphological diagnosis of urothelial neoplasms","volume":"61","author":"Montironi","year":"2008","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.03.006_bib0008","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1464-410X.2011.10664.x","article-title":"Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic","volume":"110","author":"Blick","year":"2012","journal-title":"BJU Int"},{"issue":"11","key":"10.1016\/j.urolonc.2024.03.006_bib0009","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/1756287217720401","article-title":"Optical improvements in the diagnosis of bladder cancer: implications for clinical practice","volume":"9","author":"Schubert","year":"2017","journal-title":"Ther Adv Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.03.006_bib0010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/cncy.21947","article-title":"High-grade urothelial carcinoma in urine cytology with jet black and smooth or glassy chromatin","volume":"126","author":"Renshaw","year":"2018","journal-title":"Cancer Cytopathol"},{"issue":"10","key":"10.1016\/j.urolonc.2024.03.006_bib0011","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00345-018-2567-1","article-title":"Diagnostic biomarkers in non-muscle invasive bladder cancer","volume":"37","author":"Faiena","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2024.03.006_bib0012","unstructured":"Bladder Cancer Prognosis and Survival Rates, https:\/\/www.cancer.gov\/types\/bladder\/survival\/; 2023 [accessed 27 April 2023]"},{"issue":"11","key":"10.1016\/j.urolonc.2024.03.006_bib0013","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.3390\/ijms20112657","article-title":"DNA-methylation-based detection of urological cancer in urine: overview of biomarkers and considerations on biomarker design, source of DNA, and detection technologies","volume":"20","author":"Larsen","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.urolonc.2024.03.006_bib0014","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.21037\/tau-20-1039","article-title":"Urinary extracellular vesicles: a rising star in bladder cancer management","volume":"10","author":"Urabe","year":"2021","journal-title":"Transl Androl Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2024.03.006_bib0015","doi-asserted-by":"crossref","first-page":"e06756","DOI":"10.1016\/j.heliyon.2021.e06756","article-title":"APE1 and SSRP1 is overexpressed in muscle invasive bladder cancer and associated with poor survival","volume":"7","author":"Song","year":"2021","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.urolonc.2024.03.006_bib0016","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.eururo.2016.02.046","article-title":"Extracellular vesicles and their role in urologic malignancies","volume":"70","author":"Junker","year":"2016","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.03.006_bib0017","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12929-019-0502-4","article-title":"Toward characterizing extracellular vesicles at a single-particle level","volume":"26","author":"Chiang","year":"2019","journal-title":"J Biomed Sci"},{"issue":"23","key":"10.1016\/j.urolonc.2024.03.006_bib0018","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1158\/0008-5472.CAN-17-0994","article-title":"The biology of cancer exosomes: insights and new perspectives","volume":"77","author":"Ruivo","year":"2017","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.urolonc.2024.03.006_bib0019","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/biology12010110","article-title":"Extracellular vesicles: new classification and tumor immunosuppression","volume":"12","author":"Sheta","year":"2023","journal-title":"Biology"},{"issue":"6478","key":"10.1016\/j.urolonc.2024.03.006_bib0020","doi-asserted-by":"crossref","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2024.03.006_bib0021","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","article-title":"Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles","volume":"30","author":"Colombo","year":"2014","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"4","key":"10.1016\/j.urolonc.2024.03.006_bib0022","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/21541248.2016.1215283","article-title":"Biology and biogenesis of shed microvesicles","volume":"8","author":"Tricarico","year":"2017","journal-title":"Small GTPases"},{"key":"10.1016\/j.urolonc.2024.03.006_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.620498","article-title":"Biological functions driven by mRNAs carried by extracellular vesicles in cancer","volume":"9","author":"Prieto-Vila","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.urolonc.2024.03.006_bib0024","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O'Brien","year":"2018","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.urolonc.2024.03.006_bib0025","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.708765","article-title":"Tumor suppressor mirna in cancer cells and the tumor microenvironment: mechanism of deregulation and clinical implications","volume":"11","author":"Otmani","year":"2021","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.urolonc.2024.03.006_bib0026","doi-asserted-by":"crossref","first-page":"e12093.","DOI":"10.1002\/jev2.12093","article-title":"Urinary extracellular vesicles: a position paper by the Urine Task Force of the International Society for Extracellular Vesicles","volume":"10","author":"Erdbr\u00fcgger","year":"2021","journal-title":"J Extracell Vesicles"},{"issue":"11","key":"10.1016\/j.urolonc.2024.03.006_bib0027","doi-asserted-by":"crossref","first-page":"e12877","DOI":"10.1111\/cpr.12877","article-title":"microRNA exchange via extracellular vesicles in cancer","volume":"53","author":"Vu","year":"2020","journal-title":"Cell Prolif"},{"issue":"1","key":"10.1016\/j.urolonc.2024.03.006_bib0028","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1186\/s12885-021-08926-x","article-title":"Urinary exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer","volume":"21","author":"Lin","year":"2021","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.urolonc.2024.03.006_bib0029","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1007\/s11033-021-06451-5","article-title":"Urinary exosomal microRNA-96-5p and microRNA-183-5p expression as potential biomarkers of bladder cancer","volume":"48","author":"El-Shal","year":"2021","journal-title":"Mol Biol Rep"},{"issue":"3","key":"10.1016\/j.urolonc.2024.03.006_bib0030","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11255-019-02328-6","article-title":"Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls","volume":"52","author":"G\u00fcll\u00fc Amuran","year":"2020","journal-title":"Int Urol Nephrol"},{"issue":"11","key":"10.1016\/j.urolonc.2024.03.006_bib0031","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1007\/s00432-019-03035-6","article-title":"MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer","volume":"145","author":"Baumgart","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2024.03.006_bib0032","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ijc.31849","article-title":"Urinary cell-free microRNA biomarker could discriminate bladder cancer from benign hematuria","volume":"144","author":"Piao","year":"2019","journal-title":"Int J Cancer"},{"issue":"29","key":"10.1016\/j.urolonc.2024.03.006_bib0033","doi-asserted-by":"crossref","first-page":"20658","DOI":"10.18632\/oncotarget.25057","article-title":"microRNA profiles in urine by next-generation sequencing can stratify bladder cancer subtypes","volume":"9","author":"Pardini","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.urolonc.2024.03.006_bib0034","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejps.2016.10.008","article-title":"Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression","volume":"98","author":"Andreu","year":"2017","journal-title":"Eur J Pharmaceutic Sci"},{"issue":"15","key":"10.1016\/j.urolonc.2024.03.006_bib0035","doi-asserted-by":"crossref","first-page":"24668","DOI":"10.18632\/oncotarget.14969","article-title":"MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma","volume":"8","author":"Matsuzaki","year":"2017","journal-title":"Oncotarget"},{"issue":"35","key":"10.1016\/j.urolonc.2024.03.006_bib0036","doi-asserted-by":"crossref","first-page":"58278","DOI":"10.18632\/oncotarget.17619","article-title":"Exosomes of invasive urothelial carcinoma cells are characterized by a specific miRNA expression signature","volume":"8","author":"Baumgart","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.urolonc.2024.03.006_bib0037","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1701133","article-title":"Unveiling massive numbers of cancer-related urinary-microRNA candidates via nanowires","volume":"3","author":"Yasui","year":"2017","journal-title":"Sci Adv"},{"key":"10.1016\/j.urolonc.2024.03.006_bib0038","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s12943-015-0466-2","article-title":"MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer","volume":"14","author":"Armstrong","year":"2015","journal-title":"Mol Cancer"},{"issue":"11","key":"10.1016\/j.urolonc.2024.03.006_bib0039","first-page":"2500","article-title":"A non-invasive miRNA based assay to detect bladder cancer in cell-free urine","volume":"7","author":"Long","year":"2015","journal-title":"Am J Transl Res"},{"issue":"7","key":"10.1016\/j.urolonc.2024.03.006_bib0040","article-title":"Cell-free urinary microRNA-99a and microRNA-125b are diagnostic markers for the non-invasive screening of bladder cancer","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.urolonc.2024.03.006_bib0041","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.clgc.2012.01.001","article-title":"Expression of microRNAs in the urine of patients with bladder cancer","volume":"10","author":"Wang","year":"2012","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urolonc.2024.03.006_bib0042","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2021.735868","article-title":"Biomarkers in bladder cancer surveillance","volume":"8","author":"Sugeeta","year":"2021","journal-title":"Front Surg"},{"issue":"1","key":"10.1016\/j.urolonc.2024.03.006_bib0043","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.urolonc.2020.08.016","article-title":"Urinary biomarkers in bladder cancer: a review of the current landscape and future directions","volume":"39","author":"Ng","year":"2021","journal-title":"Urol Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2024.03.006_bib0044","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/S0022-5347(05)68934-3","article-title":"Immunocyt: a new tool for detecting transitional cell cancer of the urinary tract","volume":"161","author":"Mian","year":"1999","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2024.03.006_bib0045","first-page":"120","article-title":"Critical evaluation of urinary markers for bladder cancer detection and monitoring","volume":"10","author":"Shariat","year":"2008","journal-title":"Rev Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2024.03.006_bib0046","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nrclinonc.2010.173","article-title":"Metastamirs: a stepping stone towards improved cancer management","volume":"8","author":"White","year":"2011","journal-title":"Nat Rev. Clin Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2024.03.006_bib0047","doi-asserted-by":"crossref","first-page":"e12404","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J Extracell Vesicles"},{"issue":"2","key":"10.1016\/j.urolonc.2024.03.006_bib0048","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.juro.2014.02.035","article-title":"Bladder cancer exosomes contain EDIL-3\/Del1 and facilitate cancer progression","volume":"192","author":"Beckham","year":"2014","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2024.03.006_bib0049","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrg3198","article-title":"MicroRNA profiling: approaches and considerations","volume":"13","author":"Pritchard","year":"2012","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.urolonc.2024.03.006_bib0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.yexcr.2017.05.007","article-title":"MiR-93-5p inhibits the EMT of breast cancer cells via targeting MKL-1 and STAT3","volume":"357","author":"Xiang","year":"2017","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.urolonc.2024.03.006_bib0051","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.omtn.2020.03.003","article-title":"The promising role of miR-21 as a cancer biomarker and its importance in RNA-Based therapeutics","volume":"20","author":"Bautista-S\u00e1nchez","year":"2020","journal-title":"Molecular Ther. Nucl Acids"},{"issue":"1","key":"10.1016\/j.urolonc.2024.03.006_bib0052","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13046-015-0167-0","article-title":"A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer","volume":"34","author":"Zhou","year":"2015","journal-title":"Journal of Experiment Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.urolonc.2024.03.006_bib0053","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1007\/s11033-014-3713-5","article-title":"Investigation of key miRNAs and target genes in bladder cancer using miRNA profiling and bioinformatic tools","volume":"41","author":"Canturk","year":"2014","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.urolonc.2024.03.006_bib0054","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2147\/IJN.S72904","article-title":"Clinical and pathological implications of miRNA in bladder cancer","volume":"10","author":"Braicu","year":"2015","journal-title":"Int J Nanomed"},{"issue":"2","key":"10.1016\/j.urolonc.2024.03.006_bib0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1349-7006.2009.01419.x","article-title":"Epithelial-mesenchymal transition in cancer development and its clinical significance","volume":"101","author":"Iwatsuki","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.urolonc.2024.03.006_bib0056","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.965231","article-title":"The role of miR-200 family in the regulation of hallmarks of cancer","volume":"12","author":"Klicka","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.03.006_bib0057","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3727\/096504017X14902261600566","article-title":"MicroRNA-940 targets INPP4A or GSK3\u03b2 and activates the Wnt\/\u03b2-Catenin pathway to regulate the malignant behavior of bladder cancer cells","volume":"26","author":"Wang","year":"2018","journal-title":"Oncol Res"},{"issue":"18","key":"10.1016\/j.urolonc.2024.03.006_bib0058","doi-asserted-by":"crossref","first-page":"16043","DOI":"10.18632\/oncotarget.3755","article-title":"MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1","volume":"6","author":"Peng","year":"2015","journal-title":"Oncotarget"},{"issue":"14","key":"10.1016\/j.urolonc.2024.03.006_bib0059","doi-asserted-by":"crossref","first-page":"11613","DOI":"10.3390\/ijms241411613","article-title":"Impact of Mir196a-2 genotypes on colorectal cancer risk in Taiwan","volume":"24","author":"Yueh","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924003612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924003612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T03:00:21Z","timestamp":1715742021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924003612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1078143924003612"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.03.006","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary extracellular vesicles-encapsulated miRNA signatures: A new paradigm for urinary bladder cancer diagnosis and classification","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}